MMED MiniMed (MMED) Insider Trading, Ownership & Congress Trades
Medical Devices · Surgical & medical instruments & apparatus · CIK 0002062583
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
77
13F, latest reported quarter
MiniMed insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for MiniMed Group, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
no insider purchases or sales on record
0 transactions on record
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
77 funds bought in last quarter
more than 57% of Medical Devices
Revenue
+14.3% year over year
more than 58% of Medical Devices
Margin
-10.7% net margin
more than 56% of Medical Devices
Buybacks
no share repurchases reported
Short interest
6.5% of the float short (float per yahoo 2026-10-26) · 5.9 days to cover · settled 2026-09-30
more than 73% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch MMED
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+0.9%12M
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MMED: institutional holders (13F)
13F holdings, latest reported quarter
8,334,738 sh
$124.6M
3,060,615 sh
$45.8M
2,865,703 sh
$42.8M
2,812,970 sh
$42.1M
2,000,000 sh
$29.9M
Congress trades in MMED
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
MMED planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
MMED mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
MFS Active Mid Cap ETF
$234.9K position · as of 2026-05-31
0.7%
MFS New Discovery Value Portfolio
$263.8K position · as of 2026-06-30
0.6%
Select Medical Technology and Devices Portfolio
$15.4M position · as of 2026-05-31
0.5%
MFS Mid Cap Value Fund
$63.9M position · as of 2026-06-30
0.4%
JNL/MFS Mid Cap Value Fund
$7.3M position · as of 2026-06-30
0.4%
MFS Mid Cap Value Portfolio
$2.4M position · as of 2026-06-30
0.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 77 funds added last quarter. Each figure is a federal filing, dated the day it went public.
MMED financials
Revenue growth
+14.3%
XBRL, annual
Net margin
-10.7%
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-04 | 2025-04 | 2024-04 | |
|---|---|---|---|
| Revenue | $3.1B | $2.7B | $2.5B |
| Gross profit | $1.7B | $1.5B | $1.4B |
| Operating income | -$190.0M | -$146.0M | -$69.0M |
| Net income | -$333.0M | -$213.0M | -$112.0M |
| EPS (diluted) | -1.30 | -0.84 | -0.44 |
| Operating cash flow | -$197.0M | $140.0M | $41.0M |
| Cash | $298.0M | $11.0M | n/a |
SEC XBRL, fiscal years, as known on 2026-10-28
MMED Stock Sonar score 3/7 axes
Find similar shapesCompareMMED ranks highest on risk and compliance (69th percentile) and growth (58th), and lowest on institutional and government (53rd), among Medical Devices peers.
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
